FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3003489580> ?p ?o ?g. }

• W3003489580 endingPage "110" @default.
• W3003489580 startingPage "106" @default.
• W3003489580 abstract "Objective To evaluate the safety and efficacy of shortened 8-week regimen of ledipasvir/sofosbuvir (LED/SOF) combination therapy in treatment-naïve children without cirrhosis aged 4-10 years of age with chronic hepatitis C virus (HCV) infection. Study design This observational single arm prospective study included 30 treatment-naïve children (20 males) with proved chronic HCV fulfilling inclusion criteria. Their body weights ranged from 17 to 26 kg. Four patients were excluded from the study. All the included children received a single oral dose of LED/SOF 45/200 mg for 8 weeks. Body weight, HCV-RNA, complete blood count, and liver function tests were monitored at 0, 2, 4, and 8 weeks and sustained virologic response was evaluated after 12 weeks after treatment (SVR12). The emergence of any side effects was also monitored. Results The most common risk factor (53.3%) was an parent or sibling with HCV infection. Twenty-nine patients (96.7%) were negative for HCV-RNA by week 2 of treatment and 1 patient became negative by week 4. The end of treatment response and SVR12 were 100%. Transaminases levels declined and returned to normal levels by week 2. Major side effects were fatigue in 90% (27/30) and headache in 76.7% (23/30). Side effects were minimal, tolerable, and did not interfere with daily activity or necessitate treatment discontinuation. Conclusions A shortened 8-week regimen of LED/SOF (45/200 mg) is safe and effective with 100% SVR12 in treatment-naïve children with cirrhosis aged 4-10 years with chronic HCV infection genotype 4. To evaluate the safety and efficacy of shortened 8-week regimen of ledipasvir/sofosbuvir (LED/SOF) combination therapy in treatment-naïve children without cirrhosis aged 4-10 years of age with chronic hepatitis C virus (HCV) infection. This observational single arm prospective study included 30 treatment-naïve children (20 males) with proved chronic HCV fulfilling inclusion criteria. Their body weights ranged from 17 to 26 kg. Four patients were excluded from the study. All the included children received a single oral dose of LED/SOF 45/200 mg for 8 weeks. Body weight, HCV-RNA, complete blood count, and liver function tests were monitored at 0, 2, 4, and 8 weeks and sustained virologic response was evaluated after 12 weeks after treatment (SVR12). The emergence of any side effects was also monitored. The most common risk factor (53.3%) was an parent or sibling with HCV infection. Twenty-nine patients (96.7%) were negative for HCV-RNA by week 2 of treatment and 1 patient became negative by week 4. The end of treatment response and SVR12 were 100%. Transaminases levels declined and returned to normal levels by week 2. Major side effects were fatigue in 90% (27/30) and headache in 76.7% (23/30). Side effects were minimal, tolerable, and did not interfere with daily activity or necessitate treatment discontinuation. A shortened 8-week regimen of LED/SOF (45/200 mg) is safe and effective with 100% SVR12 in treatment-naïve children with cirrhosis aged 4-10 years with chronic HCV infection genotype 4." @default.
• W3003489580 created "2020-02-07" @default.
• W3003489580 creator A5004885960 @default.
• W3003489580 creator A5012238735 @default.
• W3003489580 creator A5035816536 @default.
• W3003489580 creator A5043714619 @default.
• W3003489580 creator A5057743092 @default.
• W3003489580 creator A5069107940 @default.
• W3003489580 creator A5078206971 @default.
• W3003489580 creator A5089385325 @default.
• W3003489580 date "2020-04-01" @default.
• W3003489580 modified "2023-09-27" @default.
• W3003489580 title "Safety and Efficacy of 8 Weeks Ledipasvir/Sofosbuvir for Chronic Hepatitis C Genotype 4 in Children Aged 4-10 Years" @default.
• W3003489580 cites W1965151466 @default.
• W3003489580 cites W2004056169 @default.
• W3003489580 cites W2026642996 @default.
• W3003489580 cites W2103370354 @default.
• W3003489580 cites W2111873529 @default.
• W3003489580 cites W2113864802 @default.
• W3003489580 cites W2133036275 @default.
• W3003489580 cites W2154915093 @default.
• W3003489580 cites W2583841702 @default.
• W3003489580 cites W2612654848 @default.
• W3003489580 cites W2615797938 @default.
• W3003489580 cites W2752938505 @default.
• W3003489580 cites W2767417283 @default.
• W3003489580 cites W2777521976 @default.
• W3003489580 cites W2793909071 @default.
• W3003489580 cites W2799361355 @default.
• W3003489580 cites W2802688822 @default.
• W3003489580 cites W2810069034 @default.
• W3003489580 cites W2883638119 @default.
• W3003489580 cites W2887694472 @default.
• W3003489580 cites W2890334121 @default.
• W3003489580 cites W2893329780 @default.
• W3003489580 cites W2898026627 @default.
• W3003489580 cites W4211243282 @default.
• W3003489580 doi "https://doi.org/10.1016/j.jpeds.2019.12.034" @default.
• W3003489580 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32008767" @default.
• W3003489580 hasPublicationYear "2020" @default.
• W3003489580 type Work @default.
• W3003489580 sameAs 3003489580 @default.
• W3003489580 citedByCount "9" @default.
• W3003489580 countsByYear W30034895802020 @default.
• W3003489580 countsByYear W30034895802021 @default.
• W3003489580 countsByYear W30034895802022 @default.
• W3003489580 crossrefType "journal-article" @default.
• W3003489580 hasAuthorship W3003489580A5004885960 @default.
• W3003489580 hasAuthorship W3003489580A5012238735 @default.
• W3003489580 hasAuthorship W3003489580A5035816536 @default.
• W3003489580 hasAuthorship W3003489580A5043714619 @default.
• W3003489580 hasAuthorship W3003489580A5057743092 @default.
• W3003489580 hasAuthorship W3003489580A5069107940 @default.
• W3003489580 hasAuthorship W3003489580A5078206971 @default.
• W3003489580 hasAuthorship W3003489580A5089385325 @default.
• W3003489580 hasConcept C126322002 @default.
• W3003489580 hasConcept C187212893 @default.
• W3003489580 hasConcept C197934379 @default.
• W3003489580 hasConcept C203014093 @default.
• W3003489580 hasConcept C2522874641 @default.
• W3003489580 hasConcept C2775999097 @default.
• W3003489580 hasConcept C2776408679 @default.
• W3003489580 hasConcept C2776455275 @default.
• W3003489580 hasConcept C2777214474 @default.
• W3003489580 hasConcept C2778390639 @default.
• W3003489580 hasConcept C2778715236 @default.
• W3003489580 hasConcept C2780040827 @default.
• W3003489580 hasConcept C2781413609 @default.
• W3003489580 hasConcept C71924100 @default.
• W3003489580 hasConcept C90924648 @default.
• W3003489580 hasConceptScore W3003489580C126322002 @default.
• W3003489580 hasConceptScore W3003489580C187212893 @default.
• W3003489580 hasConceptScore W3003489580C197934379 @default.
• W3003489580 hasConceptScore W3003489580C203014093 @default.
• W3003489580 hasConceptScore W3003489580C2522874641 @default.
• W3003489580 hasConceptScore W3003489580C2775999097 @default.
• W3003489580 hasConceptScore W3003489580C2776408679 @default.
• W3003489580 hasConceptScore W3003489580C2776455275 @default.
• W3003489580 hasConceptScore W3003489580C2777214474 @default.
• W3003489580 hasConceptScore W3003489580C2778390639 @default.
• W3003489580 hasConceptScore W3003489580C2778715236 @default.
• W3003489580 hasConceptScore W3003489580C2780040827 @default.
• W3003489580 hasConceptScore W3003489580C2781413609 @default.
• W3003489580 hasConceptScore W3003489580C71924100 @default.
• W3003489580 hasConceptScore W3003489580C90924648 @default.
• W3003489580 hasFunder F4320325741 @default.
• W3003489580 hasLocation W30034895801 @default.
• W3003489580 hasLocation W30034895802 @default.
• W3003489580 hasOpenAccess W3003489580 @default.
• W3003489580 hasPrimaryLocation W30034895801 @default.
• W3003489580 hasRelatedWork W2420993274 @default.
• W3003489580 hasRelatedWork W2585250246 @default.
• W3003489580 hasRelatedWork W2606527564 @default.
• W3003489580 hasRelatedWork W2726614251 @default.
• W3003489580 hasRelatedWork W2884137513 @default.
• W3003489580 hasRelatedWork W2969696875 @default.
• W3003489580 hasRelatedWork W3024700057 @default.
• W3003489580 hasRelatedWork W3163448188 @default.

• next